Cisplatin oxidationsstufe
WebCisplatin, a class of platinum-containing anticancer drugs for the treatment of solid tumors, is a substrate of OCT2 and MATE1/MATE2-K. OCT2 is expressed in the basolateral membrane of proximal tubules and mediates the transport of cisplatin from the blood to proximal tubule cells. WebFeb 1, 2024 · Cisplatin injection is used to treat advanced cancer of the bladder, ovaries, or testicles. Cisplatin is an antineoplastic agent (cancer medicine). It interferes with the growth of cancer cells, which are eventually destroyed by the body. This medicine is to be given only by or under the direct supervision of a doctor.
Cisplatin oxidationsstufe
Did you know?
Cisplatin wird als Infusion verabreicht und kommt fast ausschließlich in Kombination mit anderen Chemotherapeutika zum Einsatz (Kombinations-Chemotherapie). Unerwünschte Wirkungen. Cisplatin gehört zu den Zytostatika, die am häufigsten zu Übelkeit, Erbrechen und Durchfall führen. See more Cisplatin (cis-Diammindichloridoplatin; DDP) ist ein Arzneistoff (Zytostatikum zur Hemmung des Zellwachstums bzw. der Zellteilung) und enthält ein komplexgebundenes Platinatom. Die Wirkung beruht auf … See more Cisplatin stellt einen planaren Komplex dar, der am zentralen Platinatom zwei cis-ständige Chloridliganden und zwei Amminliganden gebunden hat (zur genaueren … See more Monopräparate Cis-GRY (D), Platiblastin (CH), Platinol (CH), zahlreiche Generika (D, A, CH). See more • Markus Galanski, Bernhard K. Keppler: Tumorhemmende Metallverbindungen. In: Pharmazie in unserer Zeit 35(2), S. 118–122 (2006), See more Cisplatin wurde zuerst 1844 von Michele Peyrone synthetisiert, damals bekannt als Peyrones Chlorid. Es spielte eine Rolle bei der Entwicklung der Komplexchemie durch Alfred Werner. Die Entdeckung der zytostatischen Wirkung von Platinkomplexen … See more Wirkungsmechanismus Cisplatin wirkt ähnlich wie bifunktionelle Alkylantien durch Querverknüpfungen von DNA-Strängen. Der stark elektrophile Aqua-Cisplatin … See more Web1152 rows · Jun 13, 2005 · Cisplatin is a platinum based chemotherapy agent used to treat various sarcomas, carcinomas, lymphomas, and germ cell tumors. Brand Names. …
WebCisplatin is a type of chemotherapy. It destroys quickly dividing cells, such as cancer cells. Find out more about how chemotherapy works How do you have cisplatin? You have … WebOct 11, 2024 · Defining the mechanisms by which cisplatin enters hair cells remains challenging, as cisplatin can enter cultured cells (see Figure 3A) across the cell membrane via passive diffusion ( Hall et al., 2008 ). In zebrafish neuromasts, hair cells with functional TMC1 channels (see Figure 3B) are more susceptible to cisplatin-induced cytotoxicity ...
WebThe 3-hour paclitaxel infusion is associated with less myelosuppression but increased neurotoxicity compared with administering paclitaxel over 24 hours. [64313] Treatment with paclitaxel plus cisplatin significantly improved the median progression-free survival (15.5 to 18 months vs. 11.5 to 13 months) and median overall survival (35.6 to 38 … Web3-weekly cisplatin during RT or within 14 days from the last day of completion of radiation; for the weekly arm, com-pletion of RT within 66 days and administration of five of seven courses of weekly cisplatin during the RT period. The primary end point of the phase III part was OS, and secondary end points were relapse-free survival (RFS), local
Cisplatin has a number of side effects that can limit its use: • Nephrotoxicity (kidney damage) is the primary dose-limiting side effect and is of major clinical concern. Cisplatin selectively accumulates into the proximal tubule via basolateral-to-apical transport, where it disrupts mitochondrial energetics and endoplasmic reticulum Ca homeostasis and stimulates reactive oxygen species and pro-inflammatory cytokines. Multiple mitigation strate…
WebCisplatin for i njection has been administered at 75 mg/m 2 to 100 mg/m 2 intravenously per cycle once every 3 to 4 weeks o n Day 1. Other dos es and combination regimens have been used. 2.4 Advanced Bladder Cancer . Cisplatin for i njection has been administered at 50 mg/m 2 to 70 mg/m 2 intravenously per cycle once every 3 to 4 weeks. cross profile definitioncross pram silver linerWebPURPOSE Nephrotoxicity is a major dose-limiting toxicity among patients with cancer who were treated with cisplatin. Although no standard approach is available to prevent cisplatin-induced nephrotoxicity, administering intravenous isotonic saline is recommended. Additionally, mannitol combined with hydration has been evaluated, but none of them … mappa concettuale sulla pressione atmosfericaWebCisplatin for injection is a highly emetogenic antineoplastic agent; premedicate with anti-emetic agents; without antiemetic therapy, marked nausea and vomiting occur in almost all patients treated with cisplatin … mappa concettuale sulla bomba atomicaWebJun 2, 2014 · Platin in seiner ungewöhnlichen Oxidationsstufe + III: Diplatin(III)-Komplexe der Modellnukleobase 1-Methyluracil / Platinum in its Unusual Oxidation State + III: Diplatinum(III) Complexes with ... mappa concettuale sulla collinaWebAug 16, 2024 · a Development of cisplatin-resistant model in vivo. KB-3-1 xenograft mice were treated with 2 doses of cisplatin (0.5 and 5 mg/kg/i.p. on day 5 and 10). Tumor volumes (top) and cisplatin ... cross presentation mhc iWebOct 13, 2024 · Cisplatin is an effective chemotherapeutic agent for various solid tumours, but its use is limited by adverse effects in normal tissues. In particular, cisplatin is nephrotoxic and can cause acute ... mappa concettuale sulla comunicazione